These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19149693)

  • 1. Doripenem: a new addition to the carbapenem class of antimicrobials.
    Schafer JJ; Goff DA; Mangino JE
    Recent Pat Antiinfect Drug Discov; 2009 Jan; 4(1):18-28. PubMed ID: 19149693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doripenem: position in clinical practice.
    Dedhia HV; McKnight R
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):507-14. PubMed ID: 19485791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
    Korten V; Söyletir G; Yalçın AN; Oğünç D; Dokuzoğuz B; Esener H; Ulusoy S; Tünger A; Aygen B; Sümerkan B; Arman D; Dizbay M; Akova M; Hasçelik G; Eraksoy H; Başaran S; Köksal I; Bayramoğlu G; Akalın H; Sınırtaş M
    Mikrobiyol Bul; 2011 Apr; 45(2):197-209. PubMed ID: 21644063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doripenem: a new carbapenem antibiotic.
    Chahine EB; Ferrill MJ; Poulakos MN
    Am J Health Syst Pharm; 2010 Dec; 67(23):2015-24. PubMed ID: 21098373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea.
    Lee H; Ko KS; Song JH; Peck KR
    Microb Drug Resist; 2011 Mar; 17(1):37-45. PubMed ID: 20950191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative review of the carbapenems.
    Zhanel GG; Wiebe R; Dilay L; Thomson K; Rubinstein E; Hoban DJ; Noreddin AM; Karlowsky JA
    Drugs; 2007; 67(7):1027-52. PubMed ID: 17488146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study.
    Kiratisin P; Chongthaleong A; Tan TY; Lagamayo E; Roberts S; Garcia J; Davies T
    Int J Antimicrob Agents; 2012 Apr; 39(4):311-6. PubMed ID: 22386743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doripenem: an expected arrival in the treatment of infections caused by multidrug-resistant Gram-negative pathogens.
    Poulakou G; Giamarellou H
    Expert Opin Investig Drugs; 2008 May; 17(5):749-71. PubMed ID: 18447600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
    Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS
    J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doripenem: a review of its use in the treatment of bacterial infections.
    Keam SJ
    Drugs; 2008; 68(14):2021-57. PubMed ID: 18778123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of intravenous infusion of doripenem.
    Redman R; File TM
    Clin Infect Dis; 2009 Aug; 49 Suppl 1():S28-35. PubMed ID: 19619019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic profiling of doripenem, imipenem and meropenem against prevalent Gram-negative organisms in the Asia-Pacific region.
    Kiratisin P; Keel RA; Nicolau DP
    Int J Antimicrob Agents; 2013 Jan; 41(1):47-51. PubMed ID: 23127484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Doripenem: need for a new carbapenem].
    Guery BP
    Med Mal Infect; 2009 Dec; 39(12):871-6. PubMed ID: 19875257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.
    Biedenbach DJ; Giao PT; Hung Van P; Su Minh Tuyet N; Thi Thanh Nga T; Phuong DM; Vu Trung N; Badal RE
    Clin Ther; 2016 Sep; 38(9):2098-105. PubMed ID: 27612610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doripenem.
    Paterson DL; Depestel DD
    Clin Infect Dis; 2009 Jul; 49(2):291-8. PubMed ID: 19527173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of doripenem against Gram-negative pathogens: results from INVITA-A-DORI Brazilian study.
    Gales AC; Azevedo HD; Cereda RF; Girardello R; Xavier DE;
    Braz J Infect Dis; 2011; 15(6):513-20. PubMed ID: 22218508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
    Snydman DR; Jacobus NV; McDermott LA
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpreting carbapenem susceptibility testing results for Pseudomonas aeruginosa.
    Micaëlo M; Brossier F; Bréchot N; Luyt CE; Lu Q; Monsel A; Jarlier V; Aubry A
    Med Mal Infect; 2018 Aug; 48(5):365-371. PubMed ID: 29628176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of doripenem against Pseudomonas spp. and Acinetobacter spp. rods].
    Bogiel T; Deptuła A; Gospodarek E
    Med Dosw Mikrobiol; 2009; 61(4):367-74. PubMed ID: 20201327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.